Health News Releases

  • Today February 18
July 25, 2016 14:00
Octapharma to Sponsor Two Symposia at the 2016 World Federation of Hemophilia (WFH) World Congress in Orlando, USA
Octapharma will sponsor a range of activities at this year’s WFH World Congress in Orlando, USA, including two symposia and a number of posters and scientific presentations highlighting Octapharma’s r
July 21, 2016 11:25
Seattle Genetics and Takeda Announce Publication of Final Data from ADCETRIS® (Brentuximab Vedotin) Monotherapy Pivotal Phase 2 Clinical Trial in Relapsed or Refractory Classical Hodgkin Lymphoma in Blood
Seattle Genetics, Inc. (NASDAQ:SGEN) and Takeda Pharmaceutical Company Limited (TSE:4502) today announced the final data of the ADCETRIS (brentuximab vedotin) monotherapy pivotal Phase 2 clinical tria
July 20, 2016 17:35
The European Stroke Organisation and Boehringer Ingelheim launch the “Angels Initiative”, a unique healthcare initiative to improve acute stroke care across Europe
Suffering a stroke is one of the most devastating medical emergencies that can happen to a person. It is also a great challenge for the medical personnel treating the patient, trying to save their pat
July 18, 2016 11:15
Samsung Bioepis' Marketing Authorization Application for SB5 Adalimumab Biosimilar Candidate Accepted for Review by the European Medicines Agency
Samsung Bioepis Co., Ltd. today announced that the European Medicines Agency (EMA) has accepted for review the company’s Marketing Authorization Application (MAA) for SB5, a biosimilar candidate refer
July 15, 2016 10:25
Boehringer Ingelheim and University of Dundee collaborate to develop new class of medicines
Scotland--(BUSINESS WIRE)-- Boehringer Ingelheim and the University of Dundee will join forces in an exciting collaboration with the aim to develop a novel class of medicines that target disease causi
July 14, 2016 17:15
Investing in Cures for Cancer: GE Poised to Lead Industrialization of Cell Therapy Industry with Acquisition of Biosafe Group SA
GE Healthcare has acquired Biosafe Group SA, a supplier of integrated cell bioprocessing systems for the rapidly growing cell therapy and regenerative medicine industry for an undisclosed sum. The acq
July 14, 2016 13:40
Boehringer Ingelheim and Lilly Announce Clinical Trial Collaboration in Metastatic Breast Cancer
Boehringer Ingelheim and Eli Lilly and Company (NYSE:LLY) today announced a new collaboration on a Phase 1b study that will evaluate the safety and tolerability of BI 836845, Boehringer Ingelheim’s in
July 08, 2016 11:55
One of the World’s Leading Centers for Cardiovascular Medicine & Transplantation Adopts Masimo’s SedLine® Brain Function Monitoring and O3™ Regional Oximetry
Masimo (NASDAQ: MASI) announced today that Deutsches Herzzentrum Berlin (DHZB / German Heart Center Berlin) in Berlin, Germany, has adopted Masimo’s SedLine® Brain Function Monitoring and O3™ Regional
July 07, 2016 14:10
Takeda Receives European Commission Approval of ADCETRIS® (brentuximab vedotin) for Consolidation Treatment in Post-Transplant Hodgkin Lymphoma
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Commission (EC) has extended the current conditional marketing authorization of ADCETRIS® (brentuximab vedotin) and
July 06, 2016 13:50
Takeda Submits a New Drug Application for Novel, Oral Proteasome Inhibitor Ixazomib in Japan
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that it has submitted a New Drug Application (“NDA”) to the Ministry of Health, Labour and Welfare in Japan for ixazomib, the first or
July 04, 2016 13:40
Takeda to Partner with Altos Therapeutics to Develop Promising Compound for the Treatment of Gastroparesis
Takeda Pharmaceutical Company Limited (TOKYO:4502) and Altos Therapeutics LLC today jointly announced the companies have entered into a definitive agreement to further the development of Altos’s propr
June 30, 2016 18:10
INMARK™ now enrolling: first study to evaluate the effect of OFEV® (nintedanib) on biomarkers reflecting the underlying fibrotic process in IPF patients
Boehringer Ingelheim today announces that the first patient has been enrolled in a new study, INMARK™, investigating the effect of OFEV® (nintedanib) on changes in specific blood biomarkers. These cha
June 28, 2016 09:00
Mannatech Redefines Weight Loss Industry with Launch of New Fat-Loss System, TruHealth™ In Korea
Mannatech®, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today launched its first-ever fat-loss system, TruHealth, to thous
June 27, 2016 17:36
New analysis of INPULSIS® trials demonstrates efficacy of OFEV® (nintedanib) across a range of IPF patients using broader diagnostic criteria
New analysis of the INPULSIS® trials show for the first time that disease progression is similar in idiopathic pulmonary fibrosis (IPF) patients identified using a broader diagnostic definition compar
Photo: Business Wire
June 27, 2016 15:51
Sanofi and Boehringer Ingelheim Have Reached Definitive Agreements to Swap Sanofi’s Animal Health and Boehringer Ingelheim’s Consumer Healthcare Businesses
Sanofi and Boehringer Ingelheim announced today the signing of contracts to secure the strategic transaction initiated in December 2015 which consists of an exchange of Sanofi’s animal health business
June 27, 2016 10:30
Quintiles Introduces Continuous Glucose Monitoring Services to Improve Diabetes Outcomes
Quintiles today announced the launch of its new Continuous Glucose Monitoring (CGM) service offering. This new solution combines innovative, wearable technology with Quintiles’ deep therapeutic and an
June 24, 2016 16:45
PENTAX Medical Appoints Dr. Hudson Garrett, Global Chief Clinical Officer
PENTAX Medical, a division of HOYA Corporation, announced the appointment of Dr. Hudson Garrett to the position of Global Chief Clinical Officer. In this executive role, Hudson Garrett is responsible
June 24, 2016 15:35
New SunTech Medical CT40 Vital Signs Device to Feature Masimo SET® Pulse Oximetry Technology
Masimo (NASDAQ: MASI) and SunTech Medical, a Halma (LSE:HLMA) company, jointly announced today the integration of Masimo SET® pulse oximetry technology into SunTech’s CT40, a next generation spot-chec
June 24, 2016 13:35
Q2 Solutions Receives 2016 Global Supplier Award from Eli Lilly and Company
Q2 Solutions, a global clinical trials laboratory services organization, today announced that the company has received the 2016 Lilly Global Supplier Award. Q2 Solutions was one of 12 companies to rec
June 24, 2016 10:10
BioLegend Enters License Agreement with Sanquin for Peptide-MHC Assay Technology
BioLegend announces that it has licensed from Sanquin Blood Supply Foundation a novel technology to study antigen-specific T cells. Through a collaborative effort, Sanquin’s Reagents Division and The
June 22, 2016 14:05
TB Alliance and Takeda Announce Advancement of Joint Program Investigating Promising Compounds for Novel TB Therapies Through Global Health Innovative Technology Fund
The Global Alliance for TB Drug Development (Headquarters: New York, USA, “TB Alliance”) and Takeda Pharmaceutical Company Limited (Headquarters: Osaka, Japan; “Takeda”) announced that they have enter
June 22, 2016 13:30
Quintiles Unveils Solution Design Studio
Quintiles, the world’s largest provider of product development and integrated healthcare services, has opened its global Solution Design Studio where expert teams will collaborate to create technology
June 21, 2016 11:40
Mannatech: Leading the Revolution to End BMI as a Measure of Health
Mannatech®, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, is leading the health and weight loss industry by calling for the
June 20, 2016 16:00
Herbalife Partners with Global Football Star Cristiano Ronaldo to Launch New CR7 Drive Sports Drink
Herbalife, a global nutrition company, officially launched its new sports drink, CR7 Drive, at its annual Asia Pacific Extravaganza 2016, held in Seoul, Korea from June 17-19. Developed in collabor
June 17, 2016 14:45
Patient Safety Movement Applauds the Agency for Healthcare Research and Quality (AHRQ) & MedStar Health for Developing the CANDOR Toolkit
The Patient Safety Movement Foundation (PSMF) recommends that healthcare organizations around the world implement the Communication and Optimal Resolution (CANDOR) online toolkit published by the Agen
25 per page50 per page75 per page100 per page